RYHIX
Rydex Health Care Inv
1W: -2.2%
1M: -4.0%
3M: +1.8%
YTD: +10.2%
1Y: +15.6%
3Y: +35.1%
5Y: +18.7%
$152.90
+0.24 (+0.16%)
Weekly Expected Move ±2.0%
$147
$150
$153
$156
$159
ETF-Level Metrics
AUM$20M
Holdings130
Top 10 Wt22.8%
Beta0.70
% Profitable69%
Coverage91%
Portfolio Valuation
P/E21.5
P/B5.0
P/S1.9
EV/EBITDA15.7
P/FCF20.5
PEG1.11
Profitability & Returns
Gross Margin45.1%
Net Margin8.2%
ROE23.4%
ROA8.0%
ROIC20.9%
Div Yield1.11%
Leverage & Liquidity
Debt/Equity0.88
Debt/Assets0.30
Net Debt/EBITDA1.4x
Interest Cov12.0x
Current Ratio1.13
Quick Ratio0.89
Growth (YoY)
Revenue+16.5%
Net Income+15.3%
EPS+19.0%
FCF+32.7%
EBITDA+26.5%
Rev CAGR 3Y+18.5%
Quality Scores
Piotroski F6.0
Altman Z8.67
IS Quality68.3
IS Overall57.1
IS Value45.0
Median P/E19.9
Sector Breakdown
5 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 126 | 91.0% | 21.5 |
| Other | 6 | 1.8% | — |
| Financial Services | 2 | 0.7% | 10.4 |
| Technology | 1 | 0.7% | 44.0 |
| Industrials | 1 | 0.6% | 6.6 |
Smart Money Overlap
3 holdings with signals
Showing 50 of 136 holdings
· Page 1 of 3
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | LLY.SW | 3.67% | $705,464 | 767 | 38.2 | $851.6B | Healthcare |
| 2 | Johnson & Johnson | JNJ.SW | 3.25% | $626,255 | 2,562 | 29.6 | $535.1B | Healthcare |
| 3 | AbbVie Inc. | 4AB.DE | 2.57% | $494,355 | 2,273 | 74.0 | $408.1B | Healthcare |
| 4 | Merck & Co., Inc | 6MK.DE | 2.34% | $451,208 | 3,751 | 114.5 | $314.9B | Healthcare |
| 5 | UnitedHealth Group Inc. | UNH.DE | 2.09% | $401,826 | 1,485 | 23.9 | $295.9B | Healthcare |
| 6 | Thermo Fisher Scientific Inc | TN8.DE | 1.87% | $359,800 | 732 | 35.2 | $214.6B | Healthcare |
| 7 | Amgen Inc. | 4332.HK | 1.82% | $350,091 | 995 | — | $998.5B | Healthcare |
| 8 | Abbott Laboratories | ABT.SW | 1.74% | $334,602 | 3,259 | 31.4 | $125.5B | Healthcare |
| 9 | Pfizer Inc. | PFE.DE | 1.74% | $334,264 | 11,904 | 36.7 | $140.3B | Healthcare |
| 10 | Gilead Sciences Inc. | GILD.SW | 1.72% | $331,561 | 2,379 | -55.7 | $143.2B | Healthcare |
| 11 | Intuitive Surgical Inc. | 0R29.L | 1.69% | $324,537 | 704 | 44.3 | $140.2B | Healthcare |
| 12 | Danaher Corporation | DAP.DE | 1.52% | $293,122 | 1,546 | 37.9 | $134.5B | Healthcare |
| 13 | Bristol-Myers Squibb Company | BMY.SW | 1.52% | $291,605 | 4,808 | 13.5 | $87.7B | Healthcare |
| 14 | Stryker Corporation | 0R2S.L | 1.43% | $275,358 | 838 | 28.3 | $103.0B | Healthcare |
| 15 | Vertex Pharmaceuticals Incorporated | VX1.DE | 1.39% | $267,477 | 599 | 29.1 | $113.3B | Healthcare |
| 16 | Mckesson Corp. | 0JZU.L | 1.30% | $250,089 | 289 | 24.0 | $110.2B | Healthcare |
| 17 | Cencora Inc | ABC | 1.29% | $248,485 | 791 | 13.3 | $36.1B | Healthcare |
| 18 | Regeneron Pharmaceuticals, Inc. | 0R2M.L | 1.24% | $238,746 | 309 | 17.6 | $79.6B | Healthcare |
| 19 | Boston Scientific Corporation | BSX.F | 1.24% | $238,638 | 3,803 | 17.2 | $55.9B | Healthcare |
| 20 | CVS Health Corp | CVS.DE | 1.23% | $236,144 | 3,288 | 22.6 | $98.2B | Healthcare |
| 21 | The Cigna Group | CGN.DE | 1.11% | $212,866 | 798 | 11.2 | $63.4B | Healthcare |
| 22 | Elevance Health Inc. | ANTM | 1.08% | $208,438 | 712 | 2.1 | $114.6B | Healthcare |
| 23 | HCA Healthcare Inc | 0J1R.L | 1.07% | $206,333 | 436 | 14.2 | $96.2B | Healthcare |
| 24 | Zoetis Inc. | ZOE.DE | 0.93% | $178,379 | 1,509 | 11.5 | $25.9B | Healthcare |
| 25 | Cardinal Health, Inc. | 0HTG.L | 0.91% | $176,021 | 833 | 31.4 | $53.8B | Healthcare |
| 26 | Alnylam Pharmaceuticals Inc. | 0HD2.L | 0.90% | $174,038 | 526 | 36.0 | $29.7B | Healthcare |
| 27 | IDEXX Laboratories Inc. | 0J8P.L | 0.90% | $173,624 | 309 | 36.4 | $40.9B | Healthcare |
| 28 | Medtronic PLC | 2M6.DE | 0.90% | $172,953 | 1,996 | 21.1 | $98.6B | Healthcare |
| 29 | Becton, Dickinson and Company | BDXA | 0.89% | $172,167 | 1,095 | 211.6 | $55.9B | Healthcare |
| 30 | Edwards Lifesciences Corporation | EW | 0.89% | $170,410 | 2,128 | 48.9 | $49.0B | Healthcare |
| 31 | Insmed Inc | 0JAV.L | 0.85% | $164,174 | 1,004 | -27.0 | $23.7B | Healthcare |
| 32 | Novo Nordisk A/S | NVO | 0.85% | $163,648 | 4,453 | 9.5 | $165.7B | Healthcare |
| 33 | Icon PLC | ICLR | 0.84% | $162,117 | 1,465 | 37.8 | $12.4B | Healthcare |
| 34 | AstraZeneca PLC | ZEG.DE | 0.82% | $158,762 | 805 | 23.4 | $249.2B | Healthcare |
| 35 | Argenx SE | ARGNF | 0.82% | $158,464 | 217 | 33.3 | $58.2B | Healthcare |
| 36 | Alkermes PLC | ALKS | 0.81% | $155,725 | 4,404 | 103.6 | $7.0B | Healthcare |
| 37 | BEONE MEDICINES LTD | BGNE | 0.79% | $152,940 | 515 | 3.6 | $20.2B | Healthcare |
| 38 | Agilent Technologies Inc. | 0HAV.L | 0.78% | $149,428 | 1,311 | 33.0 | $53.3B | Healthcare |
| 39 | Jazz Pharmaceuticals PLC | JAZZ | 0.77% | $148,404 | 785 | 15.5 | $14.8B | Healthcare |
| 40 | GE Healthcare Technologies Inc. | GEHC | 0.76% | $147,058 | 2,066 | 18.5 | $29.0B | Healthcare |
| 41 | ResMed Inc. | 0KW4.L | 0.76% | $146,361 | 652 | 21.0 | $31.4B | Healthcare |
| 42 | Waters Corporation | 0LTI.L | 0.76% | $145,624 | 489 | 105.8 | $31.8B | Healthcare |
| 43 | IQVIA Holdings Inc. | 0JDM.L | 0.75% | $143,595 | 842 | 31.8 | $43.5B | Healthcare |
| 44 | Teva Pharmaceutical Industries Ltd. Private | — | 0.73% | $141,263 | 4,690 | — | — | — |
| 45 | NATERA INC | NTRA | 0.73% | $139,793 | 699 | -301.7 | $58.8B | Healthcare |
| 46 | United Therapeutics Corporation | UTHR | 0.72% | $138,757 | 234 | 17.9 | $23.0B | Healthcare |
| 47 | Mettler-Toledo International Inc | MER.SW | 0.72% | $138,732 | 110 | — | $54.4B | Healthcare |
| 48 | GSK plc | GSK | 0.71% | $137,037 | 2,483 | 14.8 | $94.2B | Healthcare |
| 49 | Biogen Inc | BIIB.SW | 0.70% | $134,564 | 734 | 30.0 | $20.8B | Healthcare |
| 50 | Royalty Pharma PLC | RPRX | 0.69% | $132,349 | 2,759 | 23.7 | $25.3B | Healthcare |